Advertisement
Home Authors Posts by HealthDay.com

HealthDay.com

HealthDay.com
39830 POSTS 0 COMMENTS
Children of mothers with polycystic ovary syndrome may have an increased risk for autism spectrum disorders

Maternal PCOS May Raise Odds for Autism in Offspring

0
Odds of ASD further increased among mothers with both PCOS and obesity
The combination of effective transmission of knowledge

Med Ed Can Be Improved for High-Value, Cost-Conscious Care

0
Review shows knowledge transmission, reflective practice, supportive environment aid learning
Cannabidiol might benefit some children with epilepsy whose seizures aren't controlled by approved medications

Cannabidiol Shows Promise in Pediatric Epilepsy

0
Preliminary studies link cannabidiol to seizure reduction, but drug interactions remain a concern
Compared to their international peers

Survey: U.S. PCPs Feel Ill-Prepared for Complex Care

0
For example, fewer than half feel they're prepared to manage dementia patients
Androgen deprivation therapy for prostate cancer might dramatically increase a man's risk of developing Alzheimer's disease

ADT for Prostate CA Tied to Increased Alzheimer’s Risk

0
Research suggests dose-dependent effect
The rate of vaso-occlusive crisis events is not significantly lower for children and adolescents with sickle-cell anemia receiving prasugrel versus placebo

ASH: Prasugrel Doesn’t Cut Vaso-Occlusive Crisis in Sickle Cell

0
Rate of vaso-occlusive crisis events is not lower for children receiving prasugrel versus placebo
Oral venetoclax and acalabrutinib are active in patients with relapsed or refractory chronic lymphocytic leukemia

ASH: Venetoclax, Acalabrutinib Active in Relapsed CLL

0
Two studies show beneficial effects for patients with relapsed chronic lymphocytic leukemia
A mobile stroke treatment unit is feasible for providing acute stroke treatment

Mobile Stroke Treatment Unit Feasible for Acute Stroke Care

0
Significantly shorter times from door to CT completion and to intravenous thrombolysis
For patients with inflammatory bowel disease treated with anti-tumor necrosis factor therapy

Skin Lesions for 29 Percent With Anti-TNF Treatment in IBD

0
All but 11 percent of patients were managed successfully without needing to stop treatment
Cardiometabolic outcomes and safety vary among different once-weekly glucagon-like peptide-1 receptor agonist treatments

Review Compares Outcomes, Safety for Once-Weekly GLP-1RAs

0
Greater reduction of HbA1c, fasting plasma glucose, body weight for dulaglutide, exenatide, taspoglutide